Cancer Research News

This three-time Trump supporter voted for a Democrat for the first time ever as massive medical bills outweigh her anti-abortion stance

Banda cast an early ballot for Talarico. “Never voted Democrat before today!!” she wrote in a text with blue heart emoji. The Ford Expedition rumbled …

Another Unprecedented OS Win in Extensive-Stage SCLC With Tarlatamab Maintenance

(MedPage Today) -- Overall survival (OS) in extensive-stage small-cell lung cancer (ES-SCLC) approached 2 years with tarlatamab (Imdelltra) combinatio…

Ethnic minorities in England less likely to get breast cancer diagnosis from routine screening

Exclusive: People from marginalised groups more likely to be diagnosed via urgent referral or in emergency setting, research finds People from minorit…

STAT+: After a cancer vaccine’s first success, the race is on to expand the impact

After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types. MADRID — With the first pivo…

Wellbeing support demand for cancer patients grows

Macmillan Cancer Support Jersey publishes its annual report looking back at 2025.

Tovecimig-Based Doublet Boosts Response and PFS in Advanced Biliary Tract Cancer

(MedPage Today) -- Investigational tovecimig combined with paclitaxel significantly improved the response rate and progression-free survival (PFS) in …

Novel ADC Achieves Impressive PFS Advantage in HER2-Low Metastatic Breast Cancer

(MedPage Today) -- Patients with recurrent or metastatic HER2-low breast cancer had dramatic improvement in progression-free survival (PFS) when treat…

STAT+: The ESMO presentation everyone’s been waiting for

Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical Oncology meeting in Madrid. You’re read…

Vanessa Trump says she is cancer-free six months after revealing diagnosis

The ex-wife of Donald Trump Jr, with whom she shares five children, announced in May that she had been diagnosed with breast cancer.

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treati…

Opinion: STAT readers on Elizabeth Holmes, cancer screening, and more

“Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes a STAT reader. First Op…

Chinese Drug Shows Benefit in HER2-Low Breast Cancer

(MedPage Today) -- An investigational antibody-drug conjugate (ADC) significantly reduced the risk of disease progression or death in patients with HE…

Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment

(MedPage Today) -- Cancer-related cognitive impairment (CRCI) in breast cancer survivors improved significantly after treatment with the glutamate reg…

Anika Rashaun Cause of Death: ‘Real World,’ ‘The Challenge’ Star Was 34

Reading Time: 2 minutesMTV star Anika Rashaun is dead at 34. Anika Rashaun Cause of Death: ‘Real World,’ ‘The Challenge’ Star Was 34 was originally pu…

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis oc…

STAT+: Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds

Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds. Mos…

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in …

The Truth About Sharing Your Breast Cancer Journey On Social Media

Health is a deeply personal topic. For most of us, it's something we navigate privately, which means a lot of questions are left unanswered, shrouded …

How Women With ALS Support Each Other Through a Terminal Diagnosis

ALS isn't (just) an old man's game. After receiving an ALS diagnosis in her early 30s, Brooke Eby did what was natural: crawled into bed with a party-…

Remembering STAT’s Helen Branswell

This week on the “The Readout LOUD” podcast, we remember our beloved colleague Helen Branswell, who died last week. We speak with colleagues, family, …

Gogglebox adds Hollywood megastar as Stand Up To Cancer line-up is complete

Plus a couple of comedy favourites.

STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success

As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine…

Personalised cancer vaccine expected to be approved next year

STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment And so, an…

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.  Pa…